ENDOMETRIAL

Clinical trials for ENDOMETRIAL explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL trials appear

Sign up with your email to follow new studies for ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1

New drug targets Hard-to-Treat cancers in early trial

Disease control Ongoing

This early-stage study tests an experimental drug called SGN-MesoC2 in people with advanced solid tumors (cancers that have spread or can't be removed). The drug is designed to stick to cancer cells and kill them. The study aims to find the right dose and check safety in about 19…

Matched conditions: ENDOMETRIAL

Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

ENDOMETRIAL

Get alerted when new ENDOMETRIAL trials appear

New drug targets Hard-to-Treat cancers in early trial